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Effects of Anger Awareness and Expression Training versus Relaxation
Training on Headaches: A Randomized Trial
OLGA SLAVIN-SPENNY, MARK A LUMLEY, ELYSE R. THAKUR, DANA C. NEVEDAL and ALAA M. HIJAZI,
Wayne State University

Abstract
Background and purpose: Stress contributes to headaches, and effective interventions for headaches routinely include relaxation training (RT) to directly reduce negative emotions and arousal. Yet, suppressing negative emotions,
particularly anger, appears to augment pain, and experimental studies suggest that expressing anger may reduce pain.
Therefore, we developed and tested anger awareness and expression training (AAET) on people with headaches.
Methods: Young adults with headaches (N = 147) were randomized to AAET, RT, or a wait-list control. We assessed affect during sessions, and process and outcome variables at baseline and 4 weeks after treatment.
Results: On process measures, both interventions increased self-efficacy to manage headaches, but only AAET reduced alexithymia and increased emotional processing and assertiveness. Yet, both interventions were equally effective at improving headache outcomes relative to controls.
Conclusions: Enhancing anger awareness and expression may improve chronic headaches, although not more than
RT. Researchers should study which patients are most likely to benefit from an emotional expression or emotional
reduction approach to chronic pain.
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Headaches, particularly tension and migraine
headaches, are common and frequently disabling.
It has been estimated that 47% of the population
qualify for a headache disorder diagnosis, and at
least 3% have chronic headache, defined as occurring at least 15 days per month. Social functioning and work are often impaired, and almost
half of people with chronic headache have a
mood or anxiety disorder (1).
Stress, Negative Emotions, and Pain
Psychological stress is elevated in many chronic
pain syndromes (2). Life stressors, daily hassles,
interpersonal conflict, social rejection, and the
resultant negative mood exacerbate both acute
and chronic pain (3-5). Childhood adversities and
post-traumatic stress are elevated among people
with migraines (6, 7), the frequency of stressful
1
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events is positively correlated with tension headache frequency (8), and laboratory stress triggers
tension headaches, especially in those who are
depressed (9). The recognition that stress plays a
key role in headaches has led to interventions
that directly reduce stress-induced negative emotions and physiological arousal. These interventions usually incorporate various relaxation training (RT) strategies such as progressive muscle
relaxation, deep or controlled breathing, guided
imagery, distraction, and sometimes biofeedback.
A substantial and long-standing literature documents the effectiveness of such emotion- and
arousal-reduction interventions for headache (10,
11).
More recent literature, however, suggests that
chronic stress and its emotional and physiological consequences are driven, in large part, by the
failure to adaptively experience and express key
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emotions. Both theory and empirical research
indicate the value of being aware of and experiencing the primary or activating emotions that
are naturally elicited by conflictual or stressful
experiences. For example, experiential avoidance
theory (12) posits that most psychopathology results from avoiding emotionally provocative experiences, and research on emotion regulation
demonstrates that suppressing emotions has
pathological cognitive, behavioral, and physiological consequences (13). With respect to chronic pain, both the dynamic model of affect (14),
and the stress intolerance and pain hypersensitivity model (15) propose that pain is triggered or
augmented by the failure to experience, differentiate, and process emotions. Constructs that are
linked with emotional inhibition, such as alexithymia, ambivalence over emotional expression,
and self-concealment, also are linked to greater
pain (16-19).
Anger Suppression, Expression, and Pain
Emotional states such as anxiety, fear, depression,
and anger have been studied in relation to chronic pain (20). Anger, in particular, is generated by
interpersonal victimization, violation, or rejection. Because the expression of anger is often
viewed by families, cultures, and religions as
harmful, anger is routinely suppressed or displaced, particularly among girls and women.
Thus, although anger is normal and often adaptive, it is routinely conflicted with guilt, shame,
and fear; and the resulting suppression of anger
appears to contribute to chronic stress and physical symptoms, including pain. Indeed, a series of
studies by Burns and colleagues indicates that
purposely inducing anger and then experimentally suppressing it decreases pain tolerance in
healthy people and increases pain ratings in people with low back pain (21, 22).
But does reversing anger suppression—that is,
expressing anger—reduce pain, or increase it?
Research on this topic is mixed and appears to
depend on the method used to study anger expression. Most cross-sectional, correlational
studies report that self-rated trait anger expression (e.g., “anger-out”) is related to greater pain
2
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(23). Two prospective studies using daily diary
or experience sampling are mixed, with one
showing that self-reported daily anger expression
predicts less pain in women with fibromyalgia
(24), but the other showing that anger expression
predicts greater pain (25). On the other hand,
some studies indicate that experimentally assigning people to express anger—rather than relying
on the natural experience and expression of anger—is pain-reducing. For example, eliciting anger expression during an interview leads to less
laboratory pain (26), and assigning people to expressively write about their anger reduces clinical pain (27). Furthermore, swearing increases
pain tolerance, especially among those who do
not usually swear (28), as does maintaining a
bodily posture that expresses power or dominance (29).
With respect to headaches, the roles of anger
awareness, suppression, and expression have
been examined in several studies. People with
migraine or tension headaches have elevated
alexithymia (a lack of emotional awareness and
expression) (30), and people with tension headaches have higher anger suppression than headache-free controls (31) as do people with mixed
headaches, independent of anxiety and depression (32). Women with mixed headaches report
greater anger suppression than those with tension
headaches (33). Anger suppression is positively
related to depression among both migraine sufferers (34) and mixed headache samples (35). In
addition, people with tension headaches are more
alexithymic and less assertive than controls (36),
and the lack of assertion suggests a failure to express anger in an adaptive, socially appropriate
manner (37). All of these studies, however, are
cross-sectional and correlational, leaving unanswered questions about causality. In contrast, a
daily diary study revealed that increased frustration on one day predicted the development of a
headache the next day among adolescents (38).
We know of only one relevant experimental
study, which found that anger provocation in the
laboratory led to less expressed anger among
people with migraines compared to healthy controls or those with other pain problems (39). Although these results do not directly link the sup-
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pression or expression of anger with the frequency or severity of headaches, these studies suggest
that people with headaches have, on average, increased anger suppression, or decreased anger
awareness and expression.
Although some authors have advocated emotional awareness and expression interventions to
help patients with chronic pain disorders, including headaches (40), such interventions have rarely been developed or tested. There is some evidence, however, that expressive writing about
stress (written emotional disclosure), has modest
benefits for chronic pain conditions such as fibromyalgia and rheumatoid arthritis (41), and an
uncontrolled study of emotional exposure therapy demonstrated some benefits for people with
fibromyalgia (42). Yet, interventions that facilitate awareness, experiencing, and expression of
negative emotions, particularly anger, need to be
tested for chronic pain generally and for headaches specifically. Researchers and clinicians,
however, may be hesitant to activate anger out of
concern that doing so will not help, and may
even exacerbate pain, as suggested by two older
studies (43, 44). This concern needs to be addressed through additional research.
Goals and Hypotheses
We developed and tested on people with headaches, a brief group-based anger awareness and
expression training (AAET) intervention. This
intervention seeks to reduce stress by helping
people become aware of and accept their anger
as normal and adaptive, to experience it subjectively and bodily, and to use the anger to motivate adaptive behavior, particularly assertive
communication in stressful relationships. The
intervention is brief (3 sessions) and held in
groups, in part, because we are interested in efficient protocols that reduce costs and lead to
higher uptake or adherence among patients, but
also because we hope to demonstrate that emotionally provocative interventions can be conducted much more quickly and directly than is
traditionally thought. In addition, we were guided by many studies that we and others have conducted on emotional disclosure for chronic pain
3
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and other disorders, and these studies usually involved only two to four, 20-minute sessions.
Admittedly, these emotional disclosure studies
demonstrate rather weak effects (41), and perhaps even null effects for headaches (45). But we
modeled AAET after the emotional disclosure
protocol—3 sessions—and anticipated that a
therapist’s direct guidance and clear focus on anger awareness and expression, along with the
group modeling and support, would improve
headache outcomes. We compared the effects of
AAET to RT, which we configured similarly
(same frequency, duration, and therapists) to
control for non-specific factors, and which we
viewed as a standard comparator intervention
likely to lead to headache improvements, given
the extensive documentation of RT as a successful headache management strategy (10, 11, 46,
47). Both of these interventions (AAET and RT)
were also compared to a wait-list control condition.
The comparison of AAET to RT is particularly important because these two approaches differ
fundamentally in their processes. Comparative
intervention studies typically find that the interventions yield comparable outcomes (48), leaving unanswered the question of whether the interventions actually are different. Thus, it is important to test whether the processes of the two
interventions differ as theorized. In this study, we
hypothesized that AAET would increase arousal
and negative mood during intervention sessions
relative to RT. We also hypothesized that both
interventions would increase headache management self-efficacy, but that only AAET would
influence processes that are specific to this intervention: increasing assertiveness, emotional processing, and emotional expression; and decreasing alexithymia. Finally, we tested how the two
interventions affected headache-related outcomes
4 weeks after the interventions. We hypothesized
that both interventions would surpass a wait-list
control condition in headache-related improvement, but we had no hypotheses about how
AAET would perform relative to RT.
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METHODS
Participants
Participants were 147 college students who: a)
experienced headaches several times per month
or more frequently; b) rated their typical headache as “moderate” or “severe” in intensity; and
c) desired to engage in a stress management
treatment for chronic headaches. (The latter criterion excluded participants who sought only to
obtain course credit but were unmotivated to engage in change processes, which could invalidate
a trial.) Participants were 87.8% female and 12.2%
male; their mean age was 22.1 years (SD = 6.0);
and 39.6% identified themselves as Caucasian,
25.7% as African American, 13.2% as Middle
Eastern, 11.1% as Asian/Southeast Asian/Indian,
2.8% Hispanic, 0.7% Native American, 3.5%
multiracial, and 3.5% other. The sample reported
averaging 10.35 (SD = 7.51) days of headache
per month, with a mean severity of 6.29 on a 0 to
10 scale (SD = 1.61). We were not able to classify each participant’s headache type, but 26.7%
reported that a physician had diagnosed them
with migraine. Thus, the current sample is best
described as “mixed” with respect to headache
type.
Procedures
The study was approved by the institutional review board and registered with Clinicaltrials.gov
(NCT00956969) prior to recruitment. Recruitment ran during 4 academic semesters from September 2009 through March 2011, and posttreatment assessments were completed in May
2011. Participants were recruited based upon
their responses to screening questions on an internet-based survey of all psychology students at
the start of each semester. Over 2,500 students
took the survey; approximately 15% of them met
the inclusion criteria and were contacted through
email and invited to participate by signing up for
the study on-line. The initial visit was held in
groups of up to seven students simultaneously,
during which the study was described in full, and
participants provided written informed consent.
4
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Students then completed baseline process and
outcome measures on-line.
Prior to recruitment, a computer-based randomization scheme was developed (by someone
not involved in running participants), which assigned groups of students to one of the three experimental conditions (in a 1:1:1 ratio) in randomized blocks of 3 or 6 (to ensure approximately equal sample sizes in the conditions). Participants and research assistants were blind to condition assignment until after completion of baseline
measures. Students assigned to either of the two
intervention conditions had intervention session
1 immediately, and then returned at the same day
and time 1 and 2 weeks later for intervention sessions 2 and 3. Intervention participants rated
their affect before and after each of the three sessions and returned 6 weeks after baseline (i.e., 4
weeks after session 3) for the post-treatment assessment of process and outcomes measures. Participants assigned to the wait-list control condition were dismissed after completing baseline
measures and returned 6 weeks later for the posttreatment assessment (i.e., the same time point as
the two interventions conditions).
Both of the interventions were conducted according to manuals developed for this study.
Therapists were four female doctoral students in
clinical psychology who were trained in and provided both interventions, which controlled for
therapist effects. Each of the three sessions for
both interventions was 1 hour long and conducted in a group format. In total, there were 13
AAET and 12 RT courses of intervention, and
the two interventions had very similar group sizes (M = 3.9 participants per group for AAET and
4.0 for RT). Regular supervision during intervention delivery was conducted by a doctoral clinical psychologist. If participants missed a group
session of their intervention, they were allowed
to make up the session during the subsequent
week by coming to the lab and listening to the
audiorecording of their session. (For AAET,
three participants listened to the recordings of
either or both sessions 2 and 3; and for RT: six
participants listened to session 2, three listened to
session 3, and one listened to both.)

INTERVENTIONS FOR CHRONIC HEADACHE | OLGA SLAVIN-SPENNY ET AL.

Experimental Conditions
Anger Awareness and Expression Training
(AAET). In session 1, participants were taught
that stress triggers or exacerbates headaches; inhibiting emotions—particularly anger—is a key
source of stress; and recognizing, experiencing,
and expressing anger is adaptive and can reduce
stress and improve headaches. Participants engaged in experiential exercises (speaking, yelling,
making angry facial expressions and postures) to
help them recognize, experience, and express
anger, and they kept a log during the next week
of times that they experienced anger. In session 2,
participants learned to communicate anger adaptively by identifying stressful interpersonal
events in their lives when anger should be experienced, including boundary violations and disagreements; recognizing and voicing their anger;
and engaging in role-playing exercises to practice assertive communication. Homework was to
practice assertive communication for the next
week. Session 3 involved troubleshooting difficulties in assertive communication experienced
by participants, continued role-plays, and having
participants plan in writing an assertive communication for a particularly difficult interpersonal
situation.
Relaxation Training (RT). In session 1, participants were taught that stress can trigger or exacerbate headaches, particularly by increasing
muscle tension and physiological arousal, and
that directly decreasing arousal and tension can
improve headaches. Participants were taught
progressive muscle relaxation and given a CD,
which contained this exercise plus the exercises
taught in sessions 2 and 3, to guide their daily
homework of practicing relaxation. In session 2,
the therapist explored any difficulties engaging
in progressive muscle relaxation and taught deep
breathing relaxation as well as brief applied relaxation exercises (“mini-practices”). Homework
was to practice these exercises. Session 3 taught
guided imagery relaxation and examined how to
incorporate relaxation into daily routines.

5
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Wait-list control. Participants in this condition
received no intervention but were invited to request an intervention after completing the posttreatment assessment.
Manipulation Check Measures
Affect valence, arousal, and control. Participants in the two intervention conditions rated
three affect dimensions at the beginning and end
of each of the three sessions, using a pictorial
version of the Self-Assessment Manikin, a stylized figure representing the continuum of these
dimensions (49). Affect valence was rated from 1
(positive or pleasant) to 9 (negative or unpleasant), arousal was rated 1 (low) to 9 (high), and
control was rated from 1 (low) to 9 (high).
Process Measures
Headache management self-efficacy. The 25item Headache Management Self-Efficacy Scale
(50) assessed participants’ perceived efficacy to
prevent or manage their headaches. Items were
rated on a 1 to 7 scale and averaged. The scale
had acceptable internal consistency in this sample at baseline (α = .71) and post-treatment (α
= .77). Test-retest reliability over the 6-week period between baseline and post-treatment was r
= .80. (This was calculated in the control group
only to provide an estimate of stability unbiased
by an intervention.)
Alexithymia. The 20-item Toronto Alexithymia
Scale-20 (51) assessed three facets of alexithymia: difficulty identifying feelings, difficulty
describing feelings, and externally-oriented
thinking. Items were rated from on a 1 to 5 scale
and summed. This scale is widely used and wellvalidated (52). Internal consistency in this sample was acceptable at both baseline (α = .82) and
post-treatment (α = .78). Test-retest reliability
was r = .87.
Assertiveness. The 30-item Rathus Assertiveness
Schedule (53) assessed participants’ perceptions
of how assertive they are in a range of situations.
Items were rated from 0 (very uncharacteristic)
to 6 (very characteristic) and averaged. The
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scale’s validity has been demonstrated in various
studies (53). Internal consistency was good in
this sample at both baseline (α = .86) and posttreatment (α = .87). Test-retest reliability was r
= .88.

past 2 weeks. Items were rated on a scale of 0 to
4 and averaged. We analyzed the Global Severity Index (mean of all items), which had excellent
reliability at both baseline and post-treatment (α
= .97 at both times).

Emotional processing and expression. This was
assessed with the two, 4-item Emotional Approach Coping scales (54): emotional processing
(active attempts to acknowledge and understand
emotions) and emotional expression. Items were
rated on a 1 to 4 scale and averaged. These two
scales are related to adaptive health outcomes
and are less confounded by negative affect than
are measures of emotion-focused coping (55).
Internal consistency was acceptable: (baseline, α
= .82 for both scales; post-treatment, processing
α = .84, expression α = .83). Test-retest reliability was r = .59 for processing and r = .69 for expression.

Statistical Analyses

Outcome Measures (Primary and Secondary)
Headache frequency. This was the primary outcome. Participants reported the number of days
in the last month that they experienced a headache.
Headache severity and duration. Participants
reported how painful their headaches during the
past month were, on average, from 0 (no pain at
all) to 10 (pain as bad as it can be), and how
many hours their headaches lasted, on average.
Headache disability. The 5-item Migraine Disability Assessment Scale (56) assessed the number
of days in the last month that headaches affected
participant’s social, occupational, and daily functioning; the overall score was the total number of
days across items. This measure has good reliability and validity and correlates well with diary
ratings and physician ratings of disability (56). In
this sample, the scale had acceptable reliability at
baseline (α = .72) and post-treatment (α = .75).
Psychological symptoms. The 53-item Brief
Symptom Inventory (57) assesses psychological
symptoms (e.g., anxiety, depression) over the
6
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A power analysis indicated that a sample of 120
participants (40 per condition) was needed to
have 80% power to detect a small betweengroups effect size (d = 0.25 SD), given a design
with three groups and two time points, assuming
an r = .5 correlation between baseline and posttreatment on the primary outcome, and a 2-tailed
α of .05. Given expected attrition, we targeted 50
participants per condition.
Preliminary analyses compared the three
conditions on demographics and baseline process
and outcome measures using chi-square and
analysis of variance (ANOVA) to determine the
success of randomization. Attrition analyses
compared study completers to those who did not
complete the post-treatment assessment. To confirm that the two interventions (AAET and RT)
had the expected effects on immediate affect,
between-groups t-tests compared the two interventions on change in affect valence, arousal,
and control during sessions (calculated as the
post-session minus pre-session rating, averaged
over the 3 sessions). Subsequent 1-sample t-tests
examined whether each affect changed significantly (from zero) within each intervention.
Main analyses compared the 3 conditions on
each process and outcome measure using analyses of covariance (ANCOVA), covarying each
measure’s baseline value. Significant ANCOVAs
were followed by pairwise LSD tests to determine differences among conditions. In addition,
within-group (paired) t-tests were conducted to
determine whether process and outcome
measures changed from baseline to 4-week posttreatment for each condition separately. (An alternative approach is repeated-measures ANOVA, comparing the 3 conditions across 2 times
and specifically testing condition x time interactions. We conducted such analyses, and the results were largely redundant with those from
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ANCOVAs. Thus, for simplicity, we present only the latter.)
All process and two outcome measures were
normally distributed at baseline and posttreatment, but headache frequency, duration, and
disability were positively skewed. Natural logarithm transformations brought these variables to
normality; however, analyses yielded the same
pattern of results on the original and transformed
variables, so we present data only for the original
variables. We also verified the homogeneity of
slopes assumption of ANCOVA by predicting
each post-treatment measure from condition x
baseline value interactions. All but one interaction was non-significant, indicating homogeneous slopes; however, headache management selfefficacy had heterogeneous slopes among conditions, rendering the ANCOVA less reliable (although repeated measures ANOVA yielded the
same result for this measure as ANCOVA).
We used intent-to-treat (ITT) analyses of the
full randomized sample of 147 participants;
missing post-treatment values were replaced by
participant’s own baseline values. However, we
also repeated the ANCOVAs including only
people in RT or AAET who were protocol adherent, as defined below.
Effect sizes (partial eta-squared; η²) are given
for the overall ANCOVAs; these effect sizes indicate the proportion of variance in the outcome
accounted for by the three conditions, while
holding constant baseline scores. We also give a
potentially more helpful effect size (ES), which
is the standardized difference in change between
conditions: Condition 1 (post-treatment minus
baseline value) minus Condition 2 (posttreatment minus baseline value) divided by the
pooled SD of change scores. Finally, following a
standard definition of headache improvement, we
categorized each participant as improving (or not)
at least 50% from his/her baseline to posttreatment value for each outcome. We present
the percent of participants in each condition
meeting this improvement criterion and compare
the three conditions on those percentages using
chi-squares. All analyses used a 2-tailed p-value
of .05.
7
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RESULTS
Preliminary Analyses
The three conditions did not differ on age, gender,
or baseline levels of any process or outcome
measures, suggesting that randomization successfully created equivalent groups. Figure 1 depicts
participant flow through the study. Of the 147
participants, 20 (13.6%) dropped from the study
and did not complete the post-treatment assessment. Completers and non-completers did not
differ significantly in demographics or baseline
process or outcome measures. Non-completers
did not differ significantly (p = .27) among conditions (10 from AAET, 5 from RT, and 5 waitlist controls).

Figure 1. Flow of participants through the study

Manipulation Check Analyses on Immediate
Affect
We next tested whether the two interventions
(AAET and RT) differed in their immediate affect reactions (post-session minus pre-session
change scores, averaged across the three sessions). The interventions differed on change in
negative affect, t(76) = 3.01, p = .004; the RT
condition reduced negative affect (M = -1.38, SD
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= 0.96) more than the AAET condition (M = 0.58, SD = 1.35), although negative affect decreased significantly in both conditions (p < .001
and p = .01, respectively). Similarly, the two interventions differed on change in arousal, t(76) =
4.76, p < .001; RT reduced arousal (M = -1.16,
SD = 1.58), whereas AAET increased arousal (M
= 0.48, SD = 1.45), and both of these changes
differed from zero (p < .001 and p = .045, respectively). Finally, the two interventions did not differ in change in control, t(76) = 0.39, p = .70;
both interventions had significant increases in
control (RT: M = 0.91, SD = 1.34; AAET: M =
0.80, SD = 1.23, both p < .001).

Analyses of Process Measures
Table 1 presents data on the process measures at
baseline and post-treatment for the three conditions, along with baseline-adjusted posttreatment values and within-condition change
scores. For headache management self-efficacy,
the three conditions differed at post-treatment,
F(2, 143) = 30.88, p < .001, partial η² = .30.
Compared with wait-list controls, both AAET
(ES = 0.96, p < .001) and RT (ES = 1.27, p
< .001) had greater self-efficacy, but the two interventions did not differ from each other (ES =
0.31, p = .23). Both interventions had significant
increases in self-efficacy from baseline.

Table 1. Process Measures for all three Conditions: Baseline, Post-treatment, and Baseline-Adjusted Post-treatment Means
Outcome measure

Anger Awareness
and Expression
Training
(n = 50)

Relaxation
Training
(n = 48)

Wait-list
Control Group
(n = 49)

Headache frequency

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

10.58 (8.32)
6.71 (7.23)
a
6.58 (0.72)
-3.87 (6.87)***
a
20 (40.0%)

9.06 (5.92)
6.42 (6.20)
a
7.15 (0.74)
-2.64 (4.78)***
a
17 (35.4%)

11.37 (7.98)
9.97 (6.39)
b
9.39 (0.73)
-1.40 (6.14)
b
8 (16.3%)

Headache severity

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

6.06 (1.54)
4.64 (2.02)
a
4.72 (0.27)
-1.42 (2.22)***
11 (22.0%)

6.37 (1.63)
4.54 (1.86)
a
4.51 (0.28)
-1.83 (1.97)***
10 (20.8%)

6.45 (1.67)
5.65 (2.07)
b
5.60 (0.27)
-0.80 (2.34)*
5 (10.2%)

Headache duration

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

6.39 (9.13)
5.56 (9.58)
a
5.80 (1.60)
-0.84 (10.80)
ab
15 (30.0%)

5.35 (8.17)
2.46 (3.12)
a
3.01 (1.64)
-2.89 (8.63)*
a
23 (47.9%)

9.88 (12.02)
12.15 (17.36)
b
11.36 (1.63)
2.27 (18.23)
b
11 (22.4%)

Headache disability

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

2.18 (1.62)
1.24 (1.88)
a
1.40 (0.30)
-0.94 (1.68)***
a
27 (54.0%)

2.27 (1.99)
1.34 (2.62)
a
1.46 (0.31)
-0.93 (2.18)**
a
29 (60.4%)

3.35 (3.76)
2.73 (2.46)
b
2.44 (0.31)
-0.62 (3.71)
b
13 (26.5%)

Psychological symptoms

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

1.06 (0.79)
0.74 (0.71)
a,b
0.75 (0.07)
-0.31 (0.67)**
ab
18 (36.0%)

1.08 (0.65)
0.64 (0.60)
a
0.63 (0.07)
-0.44 (0.62)***
a
21 (43.8%)

1.03 (0.79)
0.90 (0.72)
b
0.91 (0.07)
-0.13 (0.48)
b
10 (20.4%)

Note: Adjusted means were compared across the three conditions with ANCOVAs; see text for statistics. Adjusted means
with different superscripts differ significantly in post-hoc tests. Change scores are the difference between baseline and posttreatment, and the significance of each change score was determine by a paired t-test.
* p < .05; ** p < .01; *** p < . 001
8
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For the other process measures, the pattern
was different. Only AAET led to a significant
reduction in alexithymia and a significant increase in assertiveness and emotional processing
over time. The other two conditions did not
change these processes. Analyses comparing the
three conditions found that they differed in alexithymia at post-treatment, F(2, 143) = 4.25, p
= .016, partial η² = .06; AAET had less alexithymia at post-treatment than the controls (ES = 0.41, p = .004), but AAET did not differ from RT
(ES = -0.29, p = .13), nor did RT differ from control (ES -0.14, p = .17). The conditions also differed on assertiveness at post-treatment, F(2, 143)
= 4.20, p = .017, partial η² = .06; AAET led to
greater assertiveness than control (ES = 0.42, p
= .004), but AAET did not differ from RT (ES =
0.25, p = .15), nor did RT differ from control (ES
= 0.17, p = .15). Similarly, the three conditions
differed on emotional processing, F(2, 143) =
3.67, p = .03, partial η² = .05; in this case, AAET
led to greater emotional processing than both RT
(ES = 0.31, p = .04) and control (ES = 0.33, p
= .01), but RT did not differ from control (ES =
0.01, p = .67). Emotional expression did not
change over time for any of the conditions, nor
did the three conditions differ at post-treatment,
F(2, 143) = 0.90, p = .41, partial η² = .01.
Additional analyses of protocol adherent participants included only those from AAET or RT
who experienced all three sessions, either in person or by listening to the recording (AAET: n =
41, RT: n = 42). The between-condition differences noted above were unchanged. When only
participants who attended all three sessions in
person were included (AAET: n = 38, RT: n =
32), the effects were the same, except that AAET
now led to marginally greater emotional expression than both RT (p = .08) and control (p = .07),
as hypothesized.
Analyses of Outcome Measures
Table 2 presents the outcome data by condition.
There was a consistent pattern of findings. On
almost all measures, both AAET and RT had better outcomes than controls, but the two interventions did not differ between themselves.
9
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The primary outcome, headache frequency,
differed among the three conditions at posttreatment, F(2,143) = 4.17, p = .02, partial η²
= .055. Both AAET (ES = -0.33, p = .007) and
RT (ES = -0.18, p = .03) had fewer headaches at
post-treatment than wait-list controls, but AAET
did not differ from RT (ES = -0.18, p = .58).
Both interventions had significant reductions in
headache frequency from baseline to posttreatment. Fully 40% of AAET and 35.4% of RT
participants achieved at least 50% reduction in
headache frequency, both of which were significantly greater than the 16.3% of controls who
improved.
Similarly, both interventions significantly reduced pain severity over time, and the three conditions differed in severity at post-treatment,
F(2,143) = 4.43, p = .01, partial η² = .058, with
both AAET (ES = -0.18, p = .02) and RT (ES = 0.56, p = .006) having lower severity than controls; but again, AAET did not differ from RT
(ES = 0.17, p = .60). Headache disability had a
similar outcome pattern; both interventions significantly decreased disability over time, and the
three conditions differed at post-treatment,
F(2,143) = 3.59, p = .03, partial η² = .048, with
both AAET (ES -0.12, p = .02) and RT (ES = 0.11, p = .03) having less disability than controls,
but not differing from each other (ES = 0.00, p
= .87). Note that disability improved for 54% of
AAET and 60.4% of RT participants, compared
to only 26.5% of controls.
Headache duration showed a slightly different pattern. Again, the three conditions differed
at post-treatment, F(2,143) = 6.67, p = .002, partial η² = .085; both AAET (ES = -0.24, p = .02)
and RT (ES = -0.43, p < .001) led to shorter
headaches than did control, and AAET did not
differ from RT (ES = -0.25, p = .22). However,
only RT led to a significant reduction in duration
from baseline. Regarding psychological symptoms, both interventions led to significant reductions over time, and the three conditions differed
on outcomes ANCOVA, F(2,143) = 3.75, p = .03,
partial η²= .050. Here, however, the RT condition
had less psychological symptoms than the
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Table 2. Outcome Measures for all three Conditions: Baseline, Post-treatment, and Baseline-Adjusted Post-treatment Means
Outcome measure

Anger Awareness
and Expression
Training
(n = 50)

Relaxation
Training
(n = 48)

Wait-list
Control Group
(n = 49)

Headache frequency

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

10.58 (8.32)
6.71 (7.23)
a
6.58 (0.72)
-3.87 (6.87)***
a
20 (40.0%)

9.06 (5.92)
6.42 (6.20)
a
7.15 (0.74)
-2.64 (4.78)***
a
17 (35.4%)

11.37 (7.98)
9.97 (6.39)
b
9.39 (0.73)
-1.40 (6.14)
b
8 (16.3%)

Headache severity

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

6.06 (1.54)
4.64 (2.02)
a
4.72 (0.27)
-1.42 (2.22)***
11 (22.0%)

6.37 (1.63)
4.54 (1.86)
a
4.51 (0.28)
-1.83 (1.97)***
10 (20.8%)

6.45 (1.67)
5.65 (2.07)
b
5.60 (0.27)
-0.80 (2.34)*
5 (10.2%)

Headache duration

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

6.39 (9.13)
5.56 (9.58)
a
5.80 (1.60)
-0.84 (10.80)
ab
15 (30.0%)

5.35 (8.17)
2.46 (3.12)
a
3.01 (1.64)
-2.89 (8.63)*
a
23 (47.9%)

9.88 (12.02)
12.15 (17.36)
b
11.36 (1.63)
2.27 (18.23)
b
11 (22.4%)

Headache disability

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

2.18 (1.62)
1.24 (1.88)
a
1.40 (0.30)
-0.94 (1.68)***
a
27 (54.0%)

2.27 (1.99)
1.34 (2.62)
a
1.46 (0.31)
-0.93 (2.18)**
a
29 (60.4%)

3.35 (3.76)
2.73 (2.46)
b
2.44 (0.31)
-0.62 (3.71)
b
13 (26.5%)

Psychological symptoms

Baseline M (SD)
Post-tx M (SD)
Adj. M (SE)
Change M (SD)
> 50% improve n (%)

1.06 (0.79)
0.74 (0.71)
a,b
0.75 (0.07)
-0.31 (0.67)**
ab
18 (36.0%)

1.08 (0.65)
0.64 (0.60)
a
0.63 (0.07)
-0.44 (0.62)***
a
21 (43.8%)

1.03 (0.79)
0.90 (0.72)
b
0.91 (0.07)
-0.13 (0.48)
b
10 (20.4%)

Note: Adjusted means were compared across the three conditions with ANCOVAs. Adjusted means or improvement frequencies with different superscripts differ significantly. Change scores are the difference between baseline and post-treatment,
and the significance of each change score was determine by a paired t-test.
* p < .05; ** p < .01; *** p < . 001

controls (ES = -0.45, p = .007), but AAET did
not differ from RT (ES = 0.17, p = .26) or control
(ES = -0.25, p = .11).
Finally, analyses including only protocol adherent participants who experienced all three sessions in person or by audio-recording revealed
condition differences that were stronger than
found in the ITT analyses. For example, the condition effect on headache frequency was large
rather than moderate in size (partial η² = .121
vs. .055 for the ITT sample). All significant condition differences in outcomes reported above
remained significant, and AAET now had significantly less psychological symptoms than con10
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trols. Analyses on only those participants who
attended all three sessions in person were stronger yet (headache frequency partial η² = .159),
with the same pattern of condition differences
(both AAET and RT improved more than controls on all outcomes, but did not differ from
each other.)
DISCUSSION
This study has four central findings. First, and
most important, a brief group-based intervention
that enhanced the awareness, experience, and
adaptive expression of anger reduced headache-
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related outcomes (frequency, severity, duration,
disability) after 4 weeks, and surpassed a waitlist control. Second, a matched comparison intervention that taught various relaxation skills also
was effective in improving headache outcomes—
a finding that supports prior research (46, 47).
Third, the two interventions differentially influenced processes, including in-session arousal and
affect valence, as well as assertiveness, alexithymia, and emotional processing, which supports the proposal that these two interventions
have different mechanisms. Fourth, despite these
unique processes, the outcomes of the two interventions were very similar.
We conceptualize psychological interventions as falling on a continuum of emotional experiencing and processing (58). At one end are
techniques that down-regulate, minimize, or directly attenuate negative emotions and arousal.
Relaxation training by progressive muscle relaxation, controlled breathing, and distraction
exemplifies this approach, as do techniques such
as cognitive reappraisal or reframing, engaging
in pleasant activities, and logical problem solving.
Such approaches have the greatest empirical
support for various chronic pain disorders, including headaches, and are front-line interventions for most pain management behavioral interventions (10, 11, 59). Consistent with this literature, we also found that a 3-session relaxation
training protocol led to immediate reductions in
arousal during sessions and improvements in
headaches and psychological symptoms 4 weeks
later.
At the other end of the continuum are techniques that enhance the awareness, experiencing,
expression, and processing of negative emotions
resulting from life stressors or psychological
conflicts. Although emotional exposure and processing interventions have long been documented
as effective for anxiety and other emotional disorders, there has been little investigation of such
approaches for chronic pain. However, we found
that a 3-session protocol that emphasized the detrimental effects of anger suppression and encouraged the awareness, experiencing, and adaptive expression of anger also improved outcomes,
both over time and compared to a wait-list con11
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trol group. This finding is consistent with a
growing body of theory and research on the functional nature of emotion and the potential benefits that emotional awareness and expression can
have for chronic pain disorders (60). These results also counter the generally negative conclusions of two earlier studies of the effects of anger
expression for chronic pain (43, 44). Those studies, however, had substantial limitations or differences from ours; one was an uncontrolled trial
that examined only six women with the autoimmune disease, rheumatoid arthritis (47), and the
other, a controlled study, included only 9 patients
per condition (48). Moreover, both studies actually reported mixed rather than all negative findings, with improvements following the anger expression intervention in depression, although not
pain.
Both the AAET and RT interventions influenced processes as hypothesized. First, they had
very different effects on immediate affect. Relaxation training clearly decreased arousal and
reduced negative mood, whereas AAET increased arousal and led to less reduction of negative mood. These affect changes suggest that
these two interventions operated as proposed—
RT calms and improves mood immediately,
whereas AAET activates emotions, thereby increasing arousal. Regarding broader change processes, both interventions increased participants’
self-efficacy to manage headaches, which was
expected, given that both interventions had this
goal. But only AAET increased assertiveness and
emotional processing, whereas RT did not. Also,
only AAET reduced alexithymia, a construct that
has both trait and state components and that has
been found to decrease in response to emotionoriented interventions (61, 62). Emotional expression, however, did not change significantly
in response to AAET, although it showed the expected trend in analyses of those participants
who attended all sessions. The weak effect of
AAET on emotional expression might mean that
this intervention operates by increasing emotional awareness and processing even in the absence
of overt emotional expression. It should be noted,
however, that the Emotional Approach Coping
scale typically is considered a trait measure, and
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only one published study has reported increases
in emotional processing or expression with an
emotion-oriented intervention (63); thus further
study of how this measure responds to interventions is needed.
How is it, then, that the two interventions had
different processes but generally equivalent
health outcomes? The finding that different interventions have comparable outcomes is very
common in the psychological treatment literature;
this so-called “dodo bird” effect has been discussed extensively (48). We do not think that
common explanations for this pattern, such as
insufficient sample size, lack of treatment fidelity,
therapist effects, or insensitive outcome
measures, led to the outcome equivalence of the
two interventions in this study. Rather, we think
that there are three possible explanations.
First, common factors, such as participating
in an intervention, obtaining social support, receiving a plausible rationale for change, learning
new skills, and practicing new behaviors might
lead to equivalent outcomes. Indeed, in this study,
both interventions led to comparable increases in
self-efficacy to manage headaches, which is a
very robust change mechanism (64). Ruling out
many of these common factors would have required a well-designed active control condition,
which, for example, might have met in groups
for the same amount of time and received basic
education or engaged in some novel countertheoretical intervention.
Second, different change processes can yield
equivalent outcomes if there are different routes
to the same goal. Perhaps stress is reduced—and
headaches improved—by both arousal reduction
and emotional processing pathways. Unfortunately, we did not include more sensitive
measures of stress responses nor repeat them during the intervention to determine whether there
were different, specific processes leading to the
same outcome of stress reduction.
Third, nearly half of the participants in each
intervention improved clinically, but it is possible that different subgroups of participants responded to each intervention. Such subgroup responses would be diluted in the larger pool, resulting in treatment equivalence. It was likely
12
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that only some participants were in need of, open
to, and able to benefit from each intervention.
Individual differences, or patient factors, are increasingly recognized as influencing differential
treatment outcomes (65), and we have proposed
that emotional awareness and expression interventions are ideal for those people who have
emotional stress or conflict, are able to recognize
and value negative emotions, but inhibit them
due to internal fears or external contingencies
(66). Anecdotally, we observed that some participants found AAET to be empowering and freeing, as they accepted the legitimacy of their anger and began to tell others of their needs or
opinions, or declined requests, or no longer cried
or were passive in key relationships. Yet, not all
participants responded positively; for example, a
female hockey player who did not benefit from
AAET noted that she “has no trouble being angry,” but that she has difficulty opening up to
others or being vulnerable. This suggests that an
exclusive focus on anger awareness and expression is not relevant to people who need help expressing the connecting or vulnerable emotions
of sadness, guilt, or love. With respect to RT,
many participants reported enjoying the exercises,
which allowed them to “take a break” from and
feel less worried about schoolwork and other
stressors. It is not clear what types of people
might uniquely benefit from RT, but it is likely
that some people do not—perhaps those who
have trouble engaging in the exercises, dropping
their guard, or whose emotional issues are so
substantial that relaxation is insufficient. Future
analyses of these data will test baseline moderators of the effects of both interventions as well as
examine how changes in the process measures
predict changes in outcomes.
Limitations
There are several limitations of the study, in addition to those noted above. First, the use of a
college student sample limits generalizability; we
do not know the effects of AAET on patients in
clinical care, who are typically older and have
longstanding, more disabling headaches. We did,
however, screen thousands of students to identify
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our sample, which had a mean headache frequency and pain level that were clinically substantial, and participants expressed interest in
stress management to reduce headaches, suggesting that these participants are similar to clinical
patients in many ways. Nonetheless, clinic patients may be in greater need of AAET, and their
openness and response to it need to be studied.
Second, we did not obtain diagnostic information
about headaches, so our findings apply to a
mixed headache sample. It would have been better to distinguish among types of headaches (e.g.,
migraine, tension-type, or both) and determine
whether the findings apply broadly, or only to
certain types. Third, all outcome measures were
retrospective self-reports, but it would have been
preferable to assess headache variables prospectively, such as with daily diaries. Finally, a longer follow-up period would have also been helpful
to ascertain the effects of the treatment over time.
We hypothesize that effects of AAET in particular might grow over time, as participants make
continued shifts in how they experience and express their emotions and interact more genuinely
with others.
Theoretical and Clinical Implications
This study suggests that enhancing the awareness
and adaptive expression of anger can be an effective intervention, at least for young adults with
headaches. This finding has substantial implications and raises questions for both practice and
research. Although the dominant intervention for
chronic pain and headaches has been the use of
various techniques to attenuate negative emotions and physiological arousal, the current findings suggest that the opposite is also helpful.
Purposely reversing the suppression or avoidance
of negative emotions, particularly anger, in situations where anger is the appropriate and adaptive
emotion, can be helpful rather than harmful. This
is consistent with an emerging body of literature
that views emotions and emotional processes as
informative, motivational, and adaptive; and not
just as unfortunate consequences of maladaptive
coping, needing “management” or “regulation.”
We hope that research will continue to explore
13
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the value of emotional processing interventions
for headaches and other chronic pain disorders.
This study also raises clinical questions. The
current study provides no evidence that an anger
awareness and expression approach is to be preferred to an arousal reduction approach like RT,
which was equivalent to AAET on outcomes.
Furthermore, RT has more attractive immediate
effects than does AAET—greater calmness and a
more positive mood—which likely will lead to
greater participation in and adherence to RT than
AAET. We suspect that certain types of patients
will be helped preferentially by an anger awareness and expression approach, such as those with
unresolved victimization and excessive inhibition
of anger, but we currently have no evidencebased indicators or predictors to guide such intervention selection. Clearly research is needed
on relevant patient characteristics as treatment
moderators. It also may be the case that these
seemingly different approaches could be integrated or combined. For example, the transtheoretical model of change suggests that interventions that enhance awareness and motivation
should occur before those that create behavioral
and environmental change (67). Thus, it is possible that emotional awareness and processing
should ideally precede cognitive-behavioral
skills training. Future studies should explore
whether and how the two approaches might be
best combined.
In conclusion, this study demonstrated that an
intervention focused on anger awareness and expression is comparable in effectiveness to RT in
the treatment of chronic headaches. This means
that the range of interventions for headache—and
likely other chronic pain problems for which
stress plays a significant role—is broader than
we might have thought, and we encourage further exploration of such emotional activation,
experiencing, expression, and processing approaches to physical symptom disorders.

INTERVENTIONS FOR CHRONIC HEADACHE | OLGA SLAVIN-SPENNY ET AL.

CONFLICT OF INTEREST STATEMENT
The authors have no conflict of interest to disclose.
REFERENCES
1.
2.

3.

4.

5.

6.

7.
8.

9.
10.
11.

12.

13.

14

Jensen R, Stovner LJ. Epidemiology and comorbidity
of headache. Lancet Neurol. 2008; 7: 354-361.
Davis DA, Luecken LJ, Zautra AJ. Are reports of
childhood abuse related to the experience of chronic
pain in adulthood? A meta-analytic review of the literature. Clin J Pain. 2005; 5: 398-405.
Davis MC, Zautra AJ, Reich JW. Vulnerability to
stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med. 2001; 23: 215226.
Eisenberger NI, Jarcho JM, Lieberman MD, Naliboff
BD. An experimental study of shared sensitivity to
physical pain and social rejection. Pain. 2006; 126:
132-138.
Rhudy JL, Williams AE, McCabe KM, Russell, JL,
Maynard LJ. Emotional control of nociceptive reactions (ECON): Do affective valence and arousal play a
role? Pain. 2008; 136: 250-261.
Sumanen M, Rantala A, Sillanmäki LH, Mattila KJ.
Childhood adversities experienced by working-age
migraine patients. J Psychosom Res. 2007; 62: 139143.
Peterlin BL, Tietjen GE, Brandes JL, et al. Posttraumatic stress disorder in migraine. Headache. 2009; 49:
541 – 551.
White KS, Farrell AD. Anxiety and psychosocial
stress as predictors of headache and abdominal pain in
urban early adolescents. J Pediatr Psychol. 2006; 31:
582 – 596.
Janke EA, Holroyd KA, Romanek K. Depression increases onset of tension-type headache following laboratory stress. Pain. 2004; 111: 230 – 238.
Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009; 27: 445 – 465.
Rains JC, Penzien DB, McCrory DC, Gray RN. Behavioral headache treatment: History, review of the
empirical literature, and methodological critique.
Headache. 2005; 45: S91-S108.
Hayes SC, Wilson KG, Gifford EV, Follette VM,
Strosahl K. Experimental avoidance and behavioral
disorders: a functional dimensional approach to diagnosis and treatment. J Cons Clin Psychol. 1996; 64:
1152-1168.
Gross JJ. Emotion regulation: Affective, cognitive,
and social consequences. Psychophysiology, 2002; 39:
281 – 291.

DIGITALCOMMONS@WSU | 2013

14. Davis MC, Zautra AJ, Smith BW. Chronic pain, stress,
and the dynamics of affective differentiation. J Pers.
2004; 72: 1133-1160.
15. van Houdenhove B, Egle U, Luyten P. The role of life
stress in fibromyalgia. Curr Rheumatol Rep. 2005; 7:
365-370.
16. Carson JW, Keefe FJ, Lowrey KP, Porter LS, Goli V,
Fras AM. Conflict about expressing emotions and
chronic low back pain: Associations with pain and anger. J Pain. 2007; 8: 405-411.
17. Lumley MA, Neely LC, Burger AJ. The assessment of
alexithymia in medical settings: Implications for understanding and treating health problems. J Pers Assess. 2007; 89: 230-246.
18. Uysal A, Lu Q. Is self-concealment associated with
acute and chronic pain? Health Psychol. 2011; 30:
606-614.
19. van Middendorp H, Lumley, MA, Jacobs JWG, van
Doornen LJP, Bijlsma JWJ, Geenen R. Emotions and
emotional approach and avoidance strategies in fibromyalgia. J Psychosom Res. 2008; 64: 159-167.
20. Gatchel RJ, Peng Y B, Peters ML, Fuchs PN, Turk DC.
The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychol Bull.
2007; 133: 581-624.
21. Burns JW, Quartana PJ, Bruehl S. Anger inhibition
and pain: Conceptualizations, evidence, and new directions. J Behav Med. 2008; 31: 259 – 279.
22. Quartana PJ, Bounds S, Yoon KL, Goodin BR, Burns
JW. Anger suppression predicts pain, emotional, and
cardiovascular responses to the cold pressor. Ann Behav Med. 2010; 39: 211 – 221.
23. Bruehl S, Burns JW, Chung OY, Chont M. Painrelated effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.
Neurosci Biobehav Rev. 2009; 33: 475-491.
24. Van Middendorp H, Lumley MA, Moerbeek M, Jacobs JWG, Bijlsma JWJ, Geenen R. Effects of anger
and anger regulation styles on pain in daily life of
women with fibromyalgia: A diary study. Eur J Pain.
2010; 14: 176-182.
25. Bruehl S, Liu XX, Burns JW, Chont M, Jamison RN.
Associations between daily chronic pain intensity, daily anger expression, and trait anger expressiveness: An
ecological momentary assessment study. Pain. 2012;
153: 2352-2358.
26. Burns JW, Kubilus A, Bruehl S. Emotion induction
moderates effects of anger management style on acute
pain sensitivity. Pain; 2003; 106: 109-118.
27. Graham J, Lobel M, Glass P, Lokshina I. Effects of
written anger expression in chronic pain patients: making meaning from pain. J Behav Med. 2008; 31: 201212.
28. Stephens R, Umland C. Swearing as a response to
pain: Effect of daily swearing frequency. J Pain. 2011;
12: 1274-1281.

INTERVENTIONS FOR CHRONIC HEADACHE | OLGA SLAVIN-SPENNY ET AL.

29. Bohns VK, Wiltermuth SS. It hurts when I do this (or
you do that): Posture and pain tolerance. J Exp Soc
Psychol. 2012; 48: 341-345.
30. Wise TN, Mann LS, Jani N, Jani S. Illness beliefs and
alexithymia in headache patients. Headache. 1994; 34:
362-365.
31. Hatch JP, Schoenfeld LS, Boutros NN, Seleshi E,
Moore PJ, Cyr-Provost M. Anger and hostility in tension-type headache. Headache. 1991; 31: 302-304.
32. Nicholson RA, Gramling EG, Ong JC, Buenevar L.
Differences in anger expression between individuals
with and without headache after controlling for depression and anxiety. Headache. 2003; 43: 651 – 663.
33. Venable VL, Carlson CR, Wilson J. The role of anger
and depression in recurrent headache. Headache.
2001; 41: 21-30.
34. Materazzo F, Cathcart S, Pritchard D. Anger, depression, and coping interactions in headache activity and
adjustment: a controlled study. J Psychosom Res.
2000; 49: 69-75.
35. Tschannen TA, Duckro PN, Margolis RB, Tomazic TJ.
The relationship of anger, depression, and perceived
disability among headache patients. Headache. 1992;
32: 501-503.
36. Yucel B, Kora K, Ozyalcin S, Alacalar N, Ozdemir O,
Yucel A. Depression, automatic thoughts, alexithymia,
and assertiveness in patients with tension-type headache. Headache. 2002; 42: 194 – 199.
37. Rakos RF. Assertive behavior: Theory, research, and
training. 1991; London: Routledge Press.
38. Massey EK, Garnefski N, Gebhardt WA, Van Der
Leeden R. Daily frustration, cognitive coping and coping efficacy in adolescent headache: A daily diary
study. Headache. 2009; 49: 1198-1205.
39. Grothgar B, Scholz OB. On specific behavior of migraine patients in an anger-provoking situation. Headache. 1987; 27: 206-210.
40. Abbass A, Lovas D, Purdy A. Direct diagnosis and
management of emotional factors in chronic headache
patients. Cephalalgia. 2008; 28: 1305-1314.
41. Lumley MA, Sklar ER, Carty JN. Emotional disclosure interventions for chronic pain: From the laboratory to the clinic. Translational Behav Med. 2012; 2: 7381.
42. Lumley MA, Cohen JL, Stout RL, Neely LC, Sander
LM, Burger AJ. An emotional exposure-based treatment of traumatic stress for people with chronic pain:
Preliminary results for fibromyalgia syndrome. Psychother. 2008; 45: 165 – 172.
43. Beutler LE, Daldrup RJ, Engle D, Oro'-Beutler ME,
Meredith K, Boyer JT. Effects of therapeutically induced affect arousal on depressive symptoms, pain and
beta-endorphins among rheumatoid arthritis patients.
Pain. 1987; 29: 325-334.
44. Beutler LE, Daldrup R, Engle D, Guest P, Corbishley
A, Meredith KE. Family dynamics and emotional ex-

15

DIGITALCOMMONS@WSU | 2013

45.

46.
47.

48.

49.
50.

51.

52.

53.
54.

55.
56.

57.
58.

59.
60.

pression among patients with chronic pain and depression. Pain. 1988; 32: 65-72.
D’Souza PJ, Lumley MA, Kraft C, Dooley J. Relaxation training and written emotional disclosure for tension or migraine headaches: A randomized, controlled
trial. Ann Behav Med. 2008; 36: 21-32.
Blanchard EB. Behavioral therapies in the treatment of
headache. Headache Q. 1993; 4: 53-56.
Duckro PN, Cantwell-Simmons E. A review of studies
evaluating biofeedback and relaxation training in the
management of pediatric headache. Headache. 1989;
29: 428-433.
Lambert MJ, Ogles BM. The efficacy and effectiveness of psychotherapy. In M.J. Lambert (ed.), Handbook of psychotherapy and behavior change (5th ed;
pp: 139-193). 2004; New York: Wiley.
Bradley MM, Lang PJ. Measuring emotion: The selfassessment manikin and the semantic differential. J
Behav Ther Exp Psychiatry. 1994; 25: 49-59.
French DJ, Holroyd KA, Pinell C, Malinoski PT,
O’Donell F, Hill KR. Perceived self-efficacy and
headache-related disability. Headache. 2000; 40: 647
– 656.
Bagby RM, Parker JD, Taylor GJ. The twenty-item
Toronto Alexithymia Scale--I. Item selection and
cross-validation of the factor structure. J Psychosom
Res. 1994; 38: 23-32.
Taylor GJ, Bagby RM, Parker JDA. Disorders of affect regulation: Alexithymia in medical and psychiatric illness. 1997; New York, NY: Cambridge University Press.
Rathus SA. A 30-item schedule for assessing assertive
behavior. Behav Ther. 1973; 4: 398-406.
Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S.
Coping through emotional approach: scale construction and validation. J Pers Soc Psychol. 2000; 78:
1150-1169.
Austenfeld JL, Stanton AL. Coping through emotional
approach: A new look at emotion, coping, and healthrelated outcomes. J Personality. 2004; 72: 1336-1364
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headacherelated disability. Neurology. 2001; 56: S20 – S28.
Derogatis LR, Melisaratos N. The Brief Symptom
Inventory: An introductory report. Psychol Med. 1983;
13: 595-605.
Lumley MA. Beyond cognitive-behavioral therapy for
fibromyalgia: Addressing stress by emotional exposure, processing, and resolution. Arthr Res Ther, 2011;
13: 136-137.
Gatchel RJ, Rollings KH. Evidence-informed management of chronic low back pain with cognitive behavioral therapy. Spine J. 2008; 8: 40-44.
Lumley M, Cohen J, Borszcz G, et al. Pain and emotion: a biopsychosocial review of recent research. J
Clin Psychol. 2011; 67: 1-27.

INTERVENTIONS FOR CHRONIC HEADACHE | OLGA SLAVIN-SPENNY ET AL.

61. Becker-Stoll F, Gerlinghoff M The impact of a fourmonth day treatment programme on alexithymia in
eating disorders. Eur Eating Dis Rev. 2004; 12: 159163.
62. Clyne C, Blampied NM. Training in emotion regulation as a treatment for binge eating: A preliminary
study. Behav Change. 2004; 21: 269-281.
63. Zangi HA, Garratt A, Hagen KB, Stanton AL,
Mowinckel P, Finset A. Emotion regulation in patients
with rheumatic diseases: validity and responsiveness
of the Emotional Approach Coping Scale (EAC).
BMC Musculoskeletal Disorders. 2009; 10: 107.
64. Holroyd KA, Labus JS, Carlson B. Moderation and
mediation in the psychological and drug treatment of
chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain. 2009; 143:
213-222.
65. Norcross JC, Wampold B.E. What works for whom:
Tailoring psychotherapy to the person. J Clin Psychol.
2011; 67: 127-132.
66. Lumley M, Tojek T, Macklem D. The effects of written emotional disclosure among repressive and alexithymic people. In: Lepore SJ, Smyth JM, eds. The
writing cure: How expressive writing promotes health
and emotional well-being. Washington, DC: American
Psychological Association; 2002: 75-95.
67. Norcross JC, Krebs PM, Prochaska JO. Stages of
change. J Clin Psychol. 2011; 67: 143-154.

16

DIGITALCOMMONS@WSU | 2013

